Chonluten dosage chart
20 mg Vial
Chonluten is dosed at 250 mcg–4 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
- Reconstitute
- Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration.
- Typical daily range
- 250–4,000 mcg once daily (gradual titration over 8–16 weeks).
- Easy measuring
- At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.67 mcg on a U‑100 insulin syringe.
- Storage
- Lyophilized: refrigerate at 4 °C (39.2 °F) short‑term or freeze at −20 °C (−4 °F) long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing schedule
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 3.75 units (0.0375 mL) |
| Weeks 3–4 | 500 mcg (0.5 mg) | 7.5 units (0.075 mL) |
| Weeks 5–6 | 1,000 mcg (1 mg) | 15 units (0.15 mL) |
| Weeks 7–8 | 1,500 mcg (1.5 mg) | 22.5 units (0.225 mL) |
| Weeks 9–10 | 2,000 mcg (2 mg) | 30 units (0.30 mL) |
| Weeks 11–12 | 3,000 mcg (3 mg) | 45 units (0.45 mL) |
| Weeks 13–14 | 4,000 mcg (4 mg) | 60 units (0.60 mL) |
| Weeks 15–16 | 4,000 mcg (4 mg) | 60 units (0.60 mL) |
Reconstitution steps
- 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
- 2Inject slowly down the vial wall; avoid foaming.
- 3Gently swirl/roll until dissolved (do not shake).
- 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- For initial low‑volume doses (≤10 units), use 30‑ or 50‑unit insulin syringes for improved accuracy.
How This Works
Chonluten (Glu‑Asp‑Gly) is a short bioregulatory peptide studied within the Khavinson peptide bioregulator framework targeting bronchopulmonary tissues. In vitro research using monocyte/macrophage (THP‑1) cell models indicates Chonluten may modulate proliferative activity and inflammatory pathways at concentrations in the nanomolar range. Short peptides such as Chonluten typically exhibit poor oral bioavailability due to enzymatic degradation and limited mucosal permeability, supporting subcutaneous administration as the preferred route.
Potential Benefits & Side Effects
Observations from preclinical literature.
- May support bronchopulmonary tissue function and respiratory cell regulation based on bioregulator peptide research.
- Cell‑culture studies suggest modulation of inflammatory and proliferative pathways in monocyte/macrophage models.
- Short peptides in this class generally show favorable tolerability profiles in preclinical settings.
- Occasional mild injection‑site reactions (redness/itch) may occur with subcutaneous administration.
Lifestyle Factors
Complementary strategies for respiratory and general wellness.
- Maintain a balanced diet rich in antioxidants to support respiratory tissue health.
- Engage in regular aerobic activity appropriate to fitness level.
- Prioritize sleep and stress management to support immune function and recovery.
- Avoid smoking and minimize exposure to respiratory irritants.
Injection Technique
General subcutaneous guidance from clinical best‑practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45° into subcutaneous tissue using a 25–27 gauge, ⅝‑inch needle.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
important-note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
Chonluten dosage FAQs
How much bacteriostatic water do you use to reconstitute Chonluten?
Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration. for a 20 mg Vial vial. Add the water slowly against the inside wall of the vial and swirl — never shake — until the powder fully dissolves.
What does the Chonluten dosing schedule look like?
Weeks 1–2 — 250 mcg (0.25 mg) — 3.75 units (0.0375 mL); Weeks 3–4 — 500 mcg (0.5 mg) — 7.5 units (0.075 mL); Weeks 5–6 — 1,000 mcg (1 mg) — 15 units (0.15 mL); Weeks 7–8 — 1,500 mcg (1.5 mg) — 22.5 units (0.225 mL). The full table above lists every step with matching syringe units.
What are the mixing steps for Chonluten?
Draw 3.0 mL bacteriostatic water with a sterile syringe. Inject slowly down the vial wall; avoid foaming. Gently swirl/roll until dissolved (do not shake).
How should reconstituted Chonluten be stored?
Storage: Lyophilized: refrigerate at 4 °C (39.2 °F) short‑term or freeze at −20 °C (−4 °F) long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles..
How many insulin syringe units equal a Chonluten dose?
Units depend on the water volume you used. Divide your target dose by the vial concentration to get millilitres, then multiply by 100 — 1 unit on a U-100 insulin syringe is 0.01 mL. The Spartan Peptides reconstitution calculator does this conversion for you.
Is Chonluten approved for human use?
No. Chonluten is sold and referenced strictly as a research chemical. Nothing on this page is medical advice and the material is not for human consumption.
Educational and research information only. Not medical advice, not for human consumption. Values are reference figures — always verify your own math with the reconstitution calculator.
On any insulin syringe, 1 unit = 0.01 mL, so unit counts above hold across brands.